CJC-1295 w/o DAC 10mg + Ipamorelin 10mg Peptides
Set a higher standard for growth hormone secretagogue research with a clean, precisely dosed two-peptide blend.
The Well Elevation CJC-1295 w/o DAC + Ipamorelin lyophilized research peptide vial is a laboratory-grade preparation designed for controlled investigation. This non-flavored, powder-in-vial format combines two complementary GH-related peptides, delivering a total strength of 20mg per vial to support consistent experimental design and reproducibility.
- 10mg CJC-1295 w/o DAC – A growth hormone–releasing hormone analog frequently studied for its ability to promote pulsatile GH signaling in controlled models, offering a shorter, more precise profile suited to time-sensitive protocols.
- 10mg Ipamorelin – A highly selective GH secretagogue examined for synergistic application alongside GHRH analogs, with research interest focused on targeted GH release and a clean receptor interaction profile.
This dual-peptide configuration is chosen by researchers seeking to explore coordinated GH-axis dynamics under defined conditions. The lyophilized powder format supports careful handling, straightforward reconstitution in a qualified laboratory setting, and clear integration into validated methods. Expect a crisp, minimal presentation built for accuracy—no flavors, fillers, or unnecessary excipients—only the active peptides prepared for disciplined bench work.
Use in practice is directed toward controlled laboratory experimentation. Professionals may reconstitute the lyophilized contents with an appropriate sterile diluent per protocol, handle under aseptic technique, and document lot-specific parameters for traceability. For best results, store the sealed vial in a cool, dry environment protected from light, and follow institutional guidelines for stability, disposal, and documentation. This product is not a finished drug and is not intended for human or veterinary use.
Every Well Elevation peptide lot is produced with exacting standards and released only after stringent quality checks focused on identity and purity. We prioritize traceable sourcing, careful handling, and laboratory-grade packaging to preserve integrity from production to delivery. Third-party verification and lot-level documentation are available to support internal QA and compliance workflows.
USA-based and research-driven, Well Elevation is committed to transparency and rigor. For laboratory research only. Not for human consumption.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
This Product Contains
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is Ipamorelin?
Ipamorelin is a growth-hormone secretagogue that acts primarily through the ghrelin receptor pathway. It is often described as more selective than older secretagogues because it is studied for GH release with less interest in off-target hormone stimulation. For product copy, it should be described as a research peptide for endocrine signaling studies.
What is Ipamorelin typically studied for?
Ipamorelin is typically studied for endogenous growth-hormone release, GH/IGF-1-axis signaling, recovery-related models, and pulse-based endocrine research. It is commonly paired with GHRH analogs in blend products because those two signaling routes are often examined together.
What are GH peptides?
GH peptides — short for growth-hormone-related peptides — are a research category that includes two main subgroups. The first is growth-hormone-releasing hormone (GHRH) analogs, such as Sermorelin, Tesamorelin, and CJC-1295, which are studied for their interaction with the GHRH receptor. The second is growth hormone secretagogues, such as Ipamorelin, GHRP-2, GHRP-6, and Hexarelin, which are studied for their interaction with the ghrelin receptor (GHS-R1a).
Both subgroups are investigated in the research context of growth-hormone-axis biology. All GH peptide products from Well Elevation are lyophilized research compounds intended solely for in vitro laboratory investigation.
How do GH peptides differ from recombinant growth hormone?
Recombinant human growth hormone is the full 191-amino-acid human GH protein, produced via recombinant DNA technology. It is essentially identical to the endogenous hormone itself. GH peptides, by contrast, are much shorter sequences — typically on the order of a few to a few dozen amino acids — that do not act as GH themselves but rather engage upstream receptors (GHRH-R or GHS-R1a) involved in the GH signaling axis.
This makes the two categories mechanistically distinct. Recombinant GH is a replacement of the hormone itself, while GH peptides are research tools for studying the regulatory machinery that controls endogenous GH release.
What is the difference between GHRH analogs and GH secretagogues?
GHRH analogs are peptides modeled on the natural growth-hormone-releasing hormone sequence. They are studied for their ability to bind the GHRH receptor on the pituitary — the same receptor used by endogenous GHRH. Examples include Sermorelin (a GHRH 1-29 analog), Tesamorelin, and CJC-1295.
GH secretagogues are a structurally different class of peptides that act through the growth hormone secretagogue receptor (GHS-R1a), better known as the ghrelin receptor. Examples include Ipamorelin, GHRP-2, GHRP-6, and Hexarelin. The two classes engage different receptors and are therefore studied as distinct pharmacological families in research on GH signaling.
